The Contraception Initiation Feasibility in the Pediatric ED study aims to look at initiating hormonal contraception for adolescent females in the pediatric emergency department. Adolescent females who use the pediatric ED for contraception are at a higher risk of unintended pregnancy, as studies have shown that the referral leads to poor follow up. Females in the ED will be shown videos about hormonal birth control and then will receive the birth control that they select.
An estimated 400 females who present to the emergency department will participate in this trial and separated randomly into the intervention and control groups. All patients will complete a questionnaire about their sexual and medical history and then watch videos about types of hormonal birth control. Then, the intervention group will have the option of beginning the chosen contraceptive in the ED and the control group will be referred to another location to get the birth control. Participants will later be followed up with at 1, 3, 6, and 12 months to assess outcomes including continuation of contraception and unintended pregnancy.
- Female patients, 15-21 years old that present to the SLCH pediatric ED
- Report history of vaginal sex on the ED routine screening questionnaire
- Not currently using hormonal contraception
- Pregnant patients
- Currently using hormonal contraception
- Patients in foster care
- Non-English speaking patients
- Chief complaint of psychiatric concern, physical abuse or sexual abuse
- Triage acuity level 1 or 2 as they are likely to be too ill to participate
- Those with a history of stroke, venous thromboembolism, actively being treated for cancer, or who have an organ transplant
- Too ill to participate as determined by the pediatric ED health care provider (attending physician or advanced practice nurse)
- Already participated in the study
Washington University at St LouisRecruiting
Saint Louis, Missouri, United States, 63110
Contact: Kayleigh Fischer, MD 314-454-2341 firstname.lastname@example.org
Contact: Fahd Ahmad, MD 314-454-2341 email@example.com
Washington University School of Medicine
Merck Sharp & Dohme Corp.